NJBIZ Conversations: Healthcare Institute of New Jersey CEO Chrissy Buteas
by Jeffrey Kanige, December 29, 2025 In this edition of NJBIZ Conversations, HINJ CEO Chrissy Buteas talks about what she’s experienced in her time on the job, how the industry is coping with policy changes coming out of Washington and the outlook for a sector that remains critical to the state’s economy. View the interview […]
HealthCare Institute of New Jersey Statement on White House Drug Pricing Announcements
Trenton, December 19, 2025 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, issued the following statement concerning today’s White House announcement on drug pricing agreements: “New Jersey’s and America’s life sciences companies have again affirmed their commitment to lowering costs for patients around the country. These companies voluntarily […]
HealthCare Institute of New Jersey Statement on Change to Vaccine Policy
Trenton, December 5, 2025 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning the CDC’s Advisory Committee on Immunization Practices (ACIP) change to hepatitis B vaccine policy recommendations. “Hepatitis B is one of the more devastating and expensive – but most easily preventable – […]
HealthCare Institute of New Jersey Statement on IRA Price Control Announcement
Trenton, December 2, 2025 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning the latest government-imposed price controls on life-saving medicines announced by the Centers for Medicare and Medicaid Services (CMS). “As we’ve repeatedly emphasized, there are intelligent and effective ways to reduce health […]
HealthCare Institute of New Jersey Statement on US-UK Agreement on Drug Pricing
Trenton, December 1, 2025 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning today’s announced agreement between the United States and the United Kingdom on pharmaceutical prices. “For generations, America has led the world in discovering new treatments and cures for humanity’s most dreaded […]
HealthCare Institute of New Jersey Statement on Rep. Bonnie Watson Coleman’s Retirement
Trenton, November 10, 2025 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey (HINJ – www.hinj.org), issued the following statement concerning Rep. Bonnie Watson Coleman’s retirement: “Rep. Watson Coleman has been a dogged and fierce advocate for so many constituencies around New Jersey and the country, and her voice […]
HealthCare Institute of New Jersey Statement on White House Weight Loss Drug Announcement
Trenton, November 7, 2025 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, issued the following statement concerning yesterday’s White House announcement on weight loss drugs: “New Jersey’s life sciences will continue negotiating with all stakeholders on ways to lower costs for patients that don’t jeopardize our ability to […]
New Jersey’s Once-In-A-Lifetime – But Urgent – Construction Opportunity (New Jersey Globe)
By Chrissy Buteas, President and Chief Executive Officer, HealthCare Institute of New Jersey (HINJ) and William Mullen, President, New Jersey Building and Construction Trades Council October 28, 2025 ― New Jersey faces an unprecedented opportunity over the next few months as America’s pharmaceutical industry looks to double down on American investment by relocating overseas R&D and […]
HealthCare Institute of New Jersey Statement on Pharmaceutical Company Tariffs
Trenton, September 27, 2025 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, issued the following statement concerning the White House announcement on pharmaceutical company tariffs: “New Jersey’s life sciences share the goal of strengthening America’s national security and manufacturing supply chain while remaining the global leader in medical […]
Headache Relief: HINJ CEO Buteas Issues Support of NJ Life Sciences Companies (New Jersey Business Today)
September 26, 2025 ― HealthCare Institute of New Jersey (HINJ) President and CEO Chrissy Buteas issued a statement in support of life sciences companies’ role in healthcare in response to the Trump administration’s recommendations earlier this week that women limit Tylenol use during pregnancy, unless medically necessary. “From rigorous R&D and clinical trials to comprehensive approval and […]